Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Global-e Online Ltd., a leading global direct-to-consumer e-commerce platform, announced its definitive agreement to acquire Passport Global Inc., a US-based cross-border e-commerce logistics company. The acquisition aims to deepen Global-e's logistics and trade compliance capabilities, improve the post-purchase experience, and expand service offer…
Element 25 has launched a formal review of its planned high-purity manganese sulphate monohydrate (HPMSM) facility in Louisiana amid changing electric vehicle demand signals and evolving battery chemistry preferences. The company is renegotiating commercial arrangements with automakers General Motors and Stellantis, and will revisit project site, f…
Quantinuum, the quantum computing company that emerged from Honeywell’s separation and a merger with Cambridge Quantum, is pursuing a U.S. initial public offering that would value the firm at as much as $12.7 billion. The Broomfield, Colorado-based company plans to sell roughly 21.05 million shares at $45 to $50 each to raise up to $1.05 billion, f…
Meta's Family of Apps is a cash-generative, high-ROE engine trading at reasonable multiples. Reality Labs is a capital-hungry growth bet that caps the multiple for the whole company. A structural separation or clearer capital allocation that isolates RL's volatility would likely re-rate the core business and create near-term upside. Trade idea: buy…
Kenneth Jacobson, Chief Financial Officer of Avnet Inc., recently sold a block of company shares. This insider activity occurs amidst strong financial reporting from Avnet, which reported third-quarter fiscal 2026 earnings that surpassed expectations. Furthermore, the firm announced a dividend and received an upgrade from BofA Securities.
Micron is the poster child of the 2026 memory supercycle: explosive revenue, strong margins, and a fortress-like balance sheet. The stock has surged, yet fundamental cyclicality in DRAM/NAND means upside can be huge in the near-to-mid term while a brutal inventory-driven contraction remains a medium-term risk. This trade idea lays out a concrete en…
Baker Hughes has extended and expanded its contract with Petrobras to provide integrated well construction solutions in Brazil's Santos Basin. Utilizing advanced drilling technologies, the agreement supports the development of complex pre-salt offshore oil and gas fields, aiming to improve operational efficiency and unlock greater value in deepwate…
VEON Ltd. highlights a new independent Frontier Economics report showing that reducing high mobile-specific taxes in Bangladesh and Pakistan could accelerate digital adoption, GDP per capita growth, and eventually increase government tax revenues despite initial reductions. The report underscores mobile connectivity's critical role in economic part…
California Resources Corporation (NYSE: CRC) announced the first CO2 injection at its Carbon TerraVault I project, marking the launch of California's first operational carbon capture and storage (CCS) initiative. Located at the Elk Hills Field in Kern County, the project stores CO2 underground in depleted reservoirs, supporting California's carbon …
Cartesian Therapeutics has secured up to $150 million in non-dilutive financing from K2 HealthVentures, including an initial $50 million tranche, extending its cash runway into 2028. The funding supports advancement of its lead cell therapy candidate Descartes-08 through multiple clinical programs targeting autoimmune diseases such as myasthenia gr…
Appian Corporation announced that CFO Serge Tanjga will present at the TD Cowen Technology, Media & Telecom Conference and the William Blair Growth Stock Conference in late May and early June 2026. Both presentations will be webcast live and later available for replay. The company specializes in process automation technology for large enterprises a…
Olema Pharmaceuticals announced a clinical trial collaboration with Bayer to evaluate the investigational KAT6 inhibitor OP-3136 in combination with Bayer's darolutamide in metastatic castration-resistant prostate cancer. The Phase 1b/2 study will enroll approximately 36 patients and aims to assess safety, tolerability, and preliminary anti-tumor a…
REalloys Inc. announced significant progress on its commercial agreements with the Saskatchewan Research Council (SRC) to upgrade and expand SRC's rare earth processing facility. The company committed $20.6 million toward facility upgrades to increase production capacity of key rare earth metals such as Neodymium-Praseodymium, Dysprosium, and Terbi…
Outlook Therapeutics announced that the U.S. FDA has granted their appeal following the Formal Dispute Resolution process regarding their Biologics License Application for ONS-5010/LYTENAVA™ (bevacizumab-vikg) for treating neovascular age-related macular degeneration (nAMD). The FDA recognizes substantial evidence of effectiveness from clinical tri…
Tonix Pharmaceuticals disclosed results from a comprehensive retrospective U.S. real-world claims analysis involving over 261,000 fibromyalgia patients, emphasizing the high comorbidity burden and extensive healthcare resource utilization associated with the condition. The company recently commercialized TONMYA®, a novel non-opioid analgesic approv…
Jade Biosciences announced the dosing of the first participant in its Phase 2 JUNIPER clinical trial evaluating JADE101, a monoclonal antibody targeting APRIL, in patients with immunoglobulin A nephropathy (IgAN). JADE101 aims to reduce pathogenic IgA production, offering a potentially effective and convenient treatment for this chronic autoimmune …
Corbus Pharmaceuticals announced updated positive clinical results from its Phase 1/2 trial of CRB-701 (SYS6002), a next-generation Nectin-4 targeted antibody drug conjugate, showing robust efficacy in second-line oropharyngeal squamous cell carcinoma and cervical cancer. The treatment demonstrated confirmed objective response rates of 42.9% in OPS…
Spectral AI, Inc. announced that the U.S. FDA granted De Novo Classification for its DeepView System, a non-invasive AI-powered diagnostic device designed to assess burn wound healing potential. This clearance authorizes the company to start commercial distribution of the device in the United States, marking a significant milestone for Spectral AI …
Holley Performance Brands announced a Board-approved share repurchase program authorizing up to $25 million to buy back outstanding common stock. This move follows significant operational improvements including $100 million debt reduction, expanded margins, and portfolio realignment toward higher-growth brands. The program complements Holley's stra…
Axsome Therapeutics announced presentations of new clinical data for AUVELITY, its treatment for major depressive disorder, at the American Society of Clinical Psychopharmacology 2026 Annual Meeting. The data focus on efficacy in patients with anxious distress and real-world clinical outcomes, demonstrating the drug's potential benefits and expandi…
Climb Bio, a clinical-stage biotech company, announced it will present new clinical data for its immunotherapy candidates CLYM116 and budoprutug at the European Renal Association Congress 2026. CLYM116 targets APRIL to treat IgA nephropathy, with initial Phase 1 safety data to be shown, while budoprutug, an anti-CD19 antibody, is in Phase 2 trials …
Cullinan Therapeutics announced an in-person Immunology Day event to showcase promising initial and updated clinical data from over 30 patients in systemic lupus erythematosus and rheumatoid arthritis studies using CLN-978 and Velinotamig, both T cell engager therapies. The company highlighted progress in multi-dose cohorts and shared plans for adv…
Northland lowered ratings on Astera Labs, Intel and Semtech to Market Perform, warning that semiconductor valuations assume near-perfect conditions while near-term risks from supply disruptions, constrained hyperscaler finances and rising AI training costs have increased. The firm also highlighted regional utility restrictions and a strong El Nino …
AutoZone, Inc. reported an 8.4% increase in net sales to $4.8 billion for the third quarter ended May 9, 2026. Total company same store sales increased 3.9% (constant currency), driven by a 4.1% domestic same store sales growth. Operating profit rose 6.6% to $923.8 million, with diluted EPS increasing to $38.07 compared to $35.36 last year. The com…
French electricity forward prices climbed sharply as a heat wave across northwest Europe raised the prospect of nuclear generation curbs and diminished hydroelectric capacity. Month-ahead power contracts jumped to levels not seen since late March, while river and coastal temperature readings prompted market caution.
